Conceptio › Archive › HAL (France)
HAL (France)open access

The BEVATOMOX phase II trial: raltitrexed/oxaliplatin/bevacizumab vs mFOLFOX6/bevacizumab in 2nd-line metastatic colorectal cancer

Emmanuelle Samalin et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0, Bevacizumab, 1, Metastatic colorectal cancer, Oxaliplatine, Raltitrexed, Second line treatment
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 311896
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.